Shree Ganesh Bio-Tech (India) Limited (BOM:539470)
India
· Delayed Price · Currency is INR 0.610
-0.020 (-3.17%)
At close: Apr 28, 2026
BOM:539470 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 58.55 | 229.58 | 202.78 | 624.55 | 726.44 | 172.14 | Upgrade
|
| Other Revenue | -0 | - | - | - | 0 | - | Upgrade
|
| Revenue | 58.55 | 229.58 | 202.78 | 624.55 | 726.44 | 172.14 | Upgrade
|
| Revenue Growth (YoY) | -75.33% | 13.22% | -67.53% | -14.03% | 322.01% | 596.07% | Upgrade
|
| Cost of Revenue | 64.23 | 226.41 | 200.31 | 596.29 | 688.37 | 163.3 | Upgrade
|
| Gross Profit | -5.68 | 3.17 | 2.46 | 28.25 | 38.08 | 8.84 | Upgrade
|
| Selling, General & Admin | 1.4 | 1.03 | 1.95 | 2.23 | 2.47 | 0.8 | Upgrade
|
| Other Operating Expenses | 12.36 | 12.67 | 2.52 | 4.52 | 1.11 | 0.96 | Upgrade
|
| Operating Expenses | 13.76 | 13.71 | 4.47 | 6.76 | 3.59 | 1.76 | Upgrade
|
| Operating Income | -19.44 | -10.54 | -2.01 | 21.49 | 34.49 | 7.08 | Upgrade
|
| Interest & Investment Income | 14.41 | 14.41 | 10.56 | 3.31 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.21 | -0 | -0 | - | -0 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -2.83 | 3.87 | 8.55 | 24.8 | 34.49 | 7.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 2.34 | 0.5 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -2.79 | Upgrade
|
| Pretax Income | -2.83 | 3.87 | 8.55 | 27.14 | 35 | 4.28 | Upgrade
|
| Income Tax Expense | 1.09 | 1.09 | 2.34 | 6.76 | 9.74 | 1.11 | Upgrade
|
| Net Income | -3.91 | 2.78 | 6.21 | 20.39 | 25.26 | 3.17 | Upgrade
|
| Net Income to Common | -3.91 | 2.78 | 6.21 | 20.39 | 25.26 | 3.17 | Upgrade
|
| Net Income Growth | - | -55.15% | -69.55% | -19.29% | 697.39% | 34.31% | Upgrade
|
| Shares Outstanding (Basic) | 314 | 399 | 399 | 399 | 399 | 399 | Upgrade
|
| Shares Outstanding (Diluted) | 314 | 399 | 399 | 399 | 399 | 399 | Upgrade
|
| Shares Change (YoY) | -36.95% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.01 | 0.01 | 0.02 | 0.05 | 0.06 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.01 | 0.01 | 0.02 | 0.05 | 0.06 | 0.01 | Upgrade
|
| EPS Growth | - | -55.15% | -68.86% | -21.09% | 697.45% | 34.31% | Upgrade
|
| Free Cash Flow | - | -102.12 | 101.58 | 105.4 | 35.67 | 23.64 | Upgrade
|
| Free Cash Flow Per Share | - | -0.26 | 0.26 | 0.26 | 0.09 | 0.06 | Upgrade
|
| Gross Margin | -9.70% | 1.38% | 1.21% | 4.52% | 5.24% | 5.13% | Upgrade
|
| Operating Margin | -33.20% | -4.59% | -0.99% | 3.44% | 4.75% | 4.11% | Upgrade
|
| Profit Margin | -6.68% | 1.21% | 3.06% | 3.26% | 3.48% | 1.84% | Upgrade
|
| Free Cash Flow Margin | - | -44.48% | 50.09% | 16.88% | 4.91% | 13.73% | Upgrade
|
| EBITDA | -19.44 | -10.54 | -2 | 21.5 | 34.5 | 7.08 | Upgrade
|
| EBITDA Margin | -33.20% | -4.59% | -0.99% | 3.44% | 4.75% | 4.11% | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -19.44 | -10.54 | -2.01 | 21.49 | 34.49 | 7.08 | Upgrade
|
| EBIT Margin | -33.20% | -4.59% | -0.99% | 3.44% | 4.75% | 4.11% | Upgrade
|
| Effective Tax Rate | - | 28.04% | 27.40% | 24.89% | 27.82% | 26.00% | Upgrade
|
| Revenue as Reported | 75.16 | 243.99 | 213.34 | 630.19 | 726.95 | 172.14 | Upgrade
|
| Advertising Expenses | - | 0.02 | 0.07 | 0.02 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.